Inclusion Criteria:  Those between the ages of 18 - 65 Those who are women Those who were diagnosed with breast cancer for the first time and received adjuvant chemotherapy treatment Patients receiving the CA protocol; C: Cyclophophamis (Cyclophosphamide), A: Doxorubicin (Adriamycin) Those who know that they have breast cancer Those with the least education level who are literate Those who agreed to participate in the study Those who speak and understand Turkish  Exclusion Criteria:  Those receiving neoadjuvant chemotherapy treatment Those with metastases Recurrent (Recurrent) ones Those who use psychiatric drugs Those with a history of seizures Those with communication problems (hearing, seeing, speaking, etc.)